RE:RE:RE:Lot of negative articlesEven If brodalumab is negative, an approval of relistor oral should be huge positve for the stock.
For comparison, if the Walgreen conference call comment raised VRX a few dollars imagine how high the share price will be with a new drug approval.
But then again the market is nuts.